Injective (INJ) has surged 60% in 17 days after a sharp decline, now facing key resistance at $33 and the 200 SMA. This critical phase will decide if the token can maintain its momentum or face further obstacles.
Injective (INJ) has made a remarkable comeback, surging 60% in just 17 days. After a significant downtrend since its all-time high on March 13, the token hit a low on July 5, marking a 68% drop in value. Since then, INJ has shown a strong recovery.
Technical Analysis
Currently, INJ is facing resistance at the $33 level. Should it manage to surpass this threshold, it could aim for its previous all-time high of $53. However, the token must also overcome the 200 Simple Moving Average (SMA), which is currently acting as resistance.
The Moving Average Convergence Divergence (MACD) has recently issued a buy signal, but its effectiveness is contingent upon a strong trend. Currently, despite the MACD’s bullish signal, the price seems to be losing momentum.
If the uptrend falters, the $17 support level may provide a buffer against further declines. Should this support fail, the $10 support level could offer additional protection.
Bottom Line: Injective (INJ) has rebounded impressively with a 60% increase over 17 days, recovering from a significant drop. The token faces crucial resistance at $33 and the 200 SMA. While the MACD has given a buy signal, momentum appears to be waning. If the price falls, $17 and $10 are key support levels to watch. The next phase of the trend will be pivotal in determining INJ's future direction.
_webp.webp&w=1920&q=75)
_webp.webp&w=1920&q=75)